Clinical outcomes of an integrated primary–secondary model of care for individuals with complex type 2 diabetes: a non-inferiority randomised controlled trial
The aim of the study was to determine if a Beacon model of integrated care utilising general practitioners (GPs) with special interests could achieve similar clinical outcomes to a hospital-based specialist diabetes outpatient clinic.
This pragmatic non-inferiority multisite randomised controlled trial assigned individuals with complex type 2 diabetes to care delivered by a Beacon clinic or to usual care delivered by a hospital outpatient department, in a 3:1 ratio. Owing to the nature of the study, researchers were only blinded during the allocation process. Eligible participants were aged 18 or over, had been referred by their usual GP to the hospital central referral hub with type 2 diabetes and had been triaged to be seen within 30 or 90 days. The intervention consisted of diabetes management in primary care by GPs with a special interest who had been upskilled in complex diabetes under the supervision of an endocrinologist. The primary outcome was HbA1c at 12 months post-recruitment. The non-inferiority margin was 4.4 mmol/mol (0.4%). Both per-protocol and intention-to-treat analyses are reported.
Between 27 November 2012 and 14 July 2015, 352 individuals were recruited and 305 comprised the intention-to-treat sample (71 in usual care group and 234 in the Beacon model group). The Beacon model was non-inferior to usual care for both the per-protocol (difference −0.38 mmol/mol [95% CI −4.72, 3.96]; −0.03% [95% CI −0.43, 0.36]) and the intention-to-treat (difference −1.28 mmol/mol [95% CI −5.96, 3.40]; −0.12% [95% CI −0.55, 0.31]) analyses. Non-inferiority was sustained in a sensitivity analysis at 12 months. There were no statistically or clinically significant differences in the secondary outcomes of BP, lipids or quality of life as measured by the 12 item short-form health survey (SF-12v2) and the diabetes-related quality of life (DQoL-Brief) survey. Safety indicators did not differ between groups. Participant satisfaction on the eight-item client satisfaction questionnaire (CSQ-8) was good in both groups, but scores were significantly higher in the Beacon model group than the usual care group (mean [SD] 28.4 [4.9] vs 25.6 [4.9], respectively, p < 0.001).
In individuals with type 2 diabetes, a model of integrated care delivered in the community by GPs with a special interest can safely achieve clinical outcomes that are not inferior to those achieved with gold-standard hospital-based specialist outpatient clinics. Individuals receiving care in the community had greater satisfaction. Further studies will determine the cost of delivering this model of care.
Australian New Zealand Clinical Trials Registry ACTRN12612000380897
The study was funded by the Australian National Health and Medical Research Council (GNT1001157).
KeywordsGeneral practitioners with special interest Integrated care Non-inferiority randomised controlled trial Primary–secondary model of care Type 2 diabetes
Eight-item client satisfaction questionnaire
Diabetes nurse educator
Diabetes-related quality of life
General practitioner with a special interest
Hospital anxiety and depression scale
Insulin dose adjustment
Quality of life
12-item short-form health survey
The authors thank the clinical, administrative and managerial staff and participants at each of the study sites.
CLJ, AWR and HDM worked on the original idea, searched the published scientific literature and designed the methods; they were also senior clinical leads for the study implementation and contributed to data interpretation as well as revising the manuscript. MD, SJB and AWR wrote the first draft of the manuscript. MD also managed the research process and contributed to data management and interpretation. SJB also updated literature searches, undertook the data collection and contributed to data interpretation and the preparation of tables and figures. JZ and LHB contributed to research management, data collection and writing. NB conducted the data analyses supervised by the senior statistician RSW and both revised the manuscript. All authors read and approved the final submitted version. AWR is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
This research was funded by the Australian National Health and Medical Research Council (NHMRC) under the Centre of Research Excellence in Quality and Safety in Integrated Primary–Secondary Care (Grant ID: GNT1001157).
Duality of interest
The authors declare there is no duality of interest associated with this manuscript.
- 2.Winpenny EM, Miani C, Pitchforth E, King S, Roland M (2017) Improving the effectiveness and efficiency of outpatient services: a scoping review of interventions at the primary-secondary care interface. J Health Serv Res Policy 22:53–64. https://doi.org/10.1177/1355819616648982 CrossRefGoogle Scholar
- 4.World Health Organization (2016) Global report on diabetes. WHO, GenevaGoogle Scholar
- 5.Stainkey LA, Seidl IA, Johnson AJ, Tulloch GE, Pain T (2010) The challenge of long waiting lists: how we implemented a GP referral system for non-urgent specialist appointments at an Australian public hospital. BMC Health Serv Res 10(1):303. https://doi.org/10.1186/1472-6963-10-303 CrossRefPubMedCentralPubMedGoogle Scholar
- 6.Russell AW, Baxter KA, Askew DA, Tsai J, Ware RS, Jackson CL (2013) Model of care for the management of complex type 2 diabetes managed in the community by primary care physicians with specialist support: an open controlled trial. Diabet Med 30:1112–1121. https://doi.org/10.1111/dme.12251 CrossRefGoogle Scholar
- 7.Shaw S, Rosen R, Rumbold B (2011) What is integrated care? Research report. Nuffield Trust, LondonGoogle Scholar
- 9.Smith SM, Cousins G, Clyne B, Allwright S, O’Dowd T (2017) Shared care across the interface between primary and specialty care in management of long term conditions. Cochrane Database Syst Rev 2:CD004910Google Scholar
- 10.Zhang J, Burridge L, Baxter K, Donald M, Foster M, Hollingsworth S (2013) A new model of integrated primary-secondary care for complex diabetes in the community: a study protocol for a randomised controll trial. Trials 14:382. https://doi.org/10.1186/1745-6215-14-382 CrossRefPubMedCentralPubMedGoogle Scholar
- 11.Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x CrossRefGoogle Scholar
- 13.Saris-Baglama RN, Dewey CJ, Chisholm GB et al (2011) QualityMetric health outcomes™ scoring software 4.5 user’s guide. QualityMetric Incorporated, Lincoln, RI, USAGoogle Scholar
- 15.Attkisson CC, Greenfield TK (2004) The UCSF Client Satisfaction Scales: 1. The Client Satisfaction Questionnaire-8. The use of psychological testing for treatment planning and outcome assessment. Lawrence Erlbaum Associates, Mahwah, NJ, pp 799–811Google Scholar
- 17.Speight J (2010) The Hypo Awareness Questionnaire. Available from www.ahpresearch.com/. Accessed 29 Mar 2010
- 19.National Vascular Disease Prevention Alliance (2012) Guidelines for the management of absolute cardiovasular disease risk. Available from www.heartfoundation.org.au/images/uploads/publications/Absolute-CVD-Risk-Full-Guidelines.pdf. Accessed 8 Aug 2018
- 20.U.S. Department of Health and Human Servcies, Food and Drug Administration, Center for Drug Evaluation and Research (2008) Guidance for industry. Diabetes Mellitus: developing drugs and therapeutic biologics for treatment and prevention. Available from www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071624.pdf. Accessed 8 Aug 2018
- 23.Australian National Diabetes Audit (2016) Australian Quality Self-Management Audit final report. Available from www.nadc.net.au/wp-content/uploads/2016/04/ANDA-AQSMA-2016-Final-Report-Dec.pdf. Accessed 8 Aug 2018
- 24.Esposito K, Chiodini P, Bellastella G, Maiorino MI, Giugliano D (2012) Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patients. Diabetes Obes Metab 14:228–233. https://doi.org/10.1111/j.1463-1326.2011.01512.x CrossRefGoogle Scholar
- 27.Jackson C, Tsai J, Brown C, Askew D, Russell A (2010) GPs with special interests: impacting on complex diabetes care. Aust Fam Physician 39:972–974Google Scholar
- 34.Basudev N, Crosby-Nwaobi R, Thomas S, Chamley M, Murrells T, Forbes A (2016) A prospective randomized controlled study of a virtual clinic integrating primary and specialist care for patients with type 2 diabetes mellitus. Diabet Med 33:768–776. https://doi.org/10.1111/dme.12985 CrossRefGoogle Scholar
- 37.Moffatt J, Hossain D, Hansford G (2012) Physician in practice clinic: educating GPs in endocrinology through specialist-outreach. Rural Remote Health 12:2265Google Scholar